Personal information

No personal information available

Activities

Employment (6)

University of Barcelona: Barcelona, ES

2022-05-01 to present | Group Leader (Pathology and Experimental Therapy)
Employment
Source: Self-asserted source
Elisa Espinet

Biobanc HUB-ICO-IDIBELL: L'Hospitalet de Llobregat, Catalunya, ES

2022-05-01 to present | Principal Investigator (Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell))
Employment
Source: Self-asserted source
Elisa Espinet

Heidelberg Institute for Stem Cell Technology and Experimental Medicine: Heidelberg, DE

2019-09-01 to 2021-12-31 | Senior Postdoctoral Researcher
Employment
Source: Self-asserted source
Elisa Espinet

German Cancer Research Center: Heidelberg, DE

2012-09-01 to 2019-09-01 | Postdoctoral Researcher (Stem Cells and Cancer)
Employment
Source: Self-asserted source
Elisa Espinet

Institute for Research in Biomedicine: Barcelona, ES

2011-11-07 to 2012-06-30 | Bridge Postdoct (Colorectal Cancer Laboratory)
Employment
Source: Self-asserted source
Elisa Espinet

Institute for Research in Biomedicine: Barcelona, ES

2005-12-01 to 2011-11-07 | PhD student (Colorectal Cancer Laboratory)
Employment
Source: Self-asserted source
Elisa Espinet

Professional activities (8)

Spanish Ministry of Science and Innovation: Barcelona, ES

2021-10-29 | Ramon y Cajar Researcher
Distinction
Source: Self-asserted source
Elisa Espinet

Precision Oncology: Berlin, DE

2021-06 | Reviewer of the mont
Distinction
Source: Self-asserted source
Elisa Espinet

Spanish association for Oncology Research (ASEICA): Madrid, ES

2013-09-25 | 1st prize for Research in Translational Oncology
Distinction
Source: Self-asserted source
Elisa Espinet

University of Barcelona: Barcelona, ES

2013-07-31 | Extraordinary Doctorate Award
Distinction
Source: Self-asserted source
Elisa Espinet

European Molecular Biology Organization: Heidelberg, DE

2013-06-03 | EMBO long term Fellowship
Distinction
Source: Self-asserted source
Elisa Espinet

German Cancer Research Center: Heidelberg, DE

2012-12-20 | DKFZ Postdoctoral Fellowship
Distinction
Source: Self-asserted source
Elisa Espinet

Spanish Ministry of Education and Science: Barcelona, ES

2006-10-01 | PhD Research Fellowship (FPI)
Distinction
Source: Self-asserted source
Elisa Espinet

Parc Científic Barcelona: Barcelona, ES

2005-12-01 | PhD Student Fellowship
Distinction
Source: Self-asserted source
Elisa Espinet

Works (39)

A novel empeROR of pancreatic malignancy

The EMBO Journal
2023-07-17 | Journal article
Contributors: Irene Peñuelas‐Haro; Elisa Espinet
Source: check_circle
Crossref

Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer.

Cell reports
2023-05 | Journal article
Contributors: Saini M; Schmidleitner L; Moreno HD; Donato E; Falcone M; Bartsch JM; Klein C; Vogel V; Würth R; Pfarr N et al.
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

HAPLN1 potentiates peritoneal metastasis in pancreatic cancer

Nature Communications
2023-04-24 | Journal article
Contributors: Lena Wiedmann; Francesca De Angelis Rigotti; Nuria Vaquero-Siguero; Elisa Donato; Elisa Espinet; Iris Moll; Elisenda Alsina-Sanchis; Hanibal Bohnenberger; Elena Fernandez-Florido; Ronja Mülfarth et al.
Source: check_circle
Crossref

Practical Considerations for Complex Tissue Dissociation for Single-Cell Transcriptomics.

Methods in molecular biology (Clifton, N.J.)
2023-01 | Journal article
Contributors: Pohl ST; Prada ML; Espinet E; Jurkowska R
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Mechanisms of PDAC subtype heterogeneity and therapy response.

Trends in cancer
2022-09 | Journal article
Contributors: Espinet E; Klein L; Puré E; Singh SK
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype.

Gut
2022-08 | Journal article
Contributors: Liffers ST; Godfrey L; Frohn L; Haeberle L; Yavas A; Vesce R; Goering W; Opitz FV; Stoecklein N; Knoefel WT et al.
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer

JCI Insight
2022-08-22 | Journal article
Contributors: Niklas Krebs; Lukas Klein; Florian Wegwitz; Elisa Espinet; Hans Carlo Maurer; Mengyu Tu; Frederike Penz; Stefan Küffer; Xingbo Xu; Hanibal Bohnenberger et al.
Source: check_circle
Crossref

Pancreatic Organoids for Regenerative Medicine and Cancer Research.

Frontiers in cell and developmental biology
2022-05 | Journal article
Contributors: Casamitjana J; Espinet E; Rovira M
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Selenocysteine metabolism is a targetable vulnerability in<i>MYCN</i>-amplified cancers

2022-05 | Preprint
Contributors: Alborzinia H; Chen Z; Yildiz U; Freitas FP; Vogel FC; Varga J; Batani J; Bartenhagen C; Schmitz W; Büchel G et al.
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

HAPLN1 is a driver for peritoneal carcinomatosis in pancreatic cancer

2022-05-30 | Preprint
Contributors: Lena Wiedmann; Francesca De Angelis Rigotti; Nuria Vaquero-Siguero; Elisa Donato; Elisa Espinet; Iris Moll; Elisenda Alsina-Sanchis; Ronja Mülfarth; Margherita Vacca; Jennifer Gerwing et al.
Source: check_circle
Crossref

On the Origin of Pancreatic Cancer.

Cellular and molecular gastroenterology and hepatology
2021-12 | Journal article
Contributors: Backx E; Coolens K; Van den Bossche JL; Houbracken I; Espinet E; Rooman I
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer

Nature Cancer
2021-11-15 | Journal article
Contributors: Mengyu Tu; Lukas Klein; Elisa Espinet; Theodoros Georgomanolis; Florian Wegwitz; Xiaojuan Li; Laura Urbach; Adi Danieli-Mackay; Stefan Küffer; Kamil Bojarczuk et al.
Source: check_circle
Crossref

Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis.

Science translational medicine
2021-09 | Journal article
Contributors: Singhal M; Gengenbacher N; Abdul Pari AA; Kamiyama M; Hai L; Kuhn BJ; Kallenberg DM; Kulkarni SR; Camilli C; Preuß SF et al.
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting.

Gastroenterology
2021-06 | Journal article
Contributors: Hessmann E; Schneider G; 1(st) Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.

Viruses
2021-05-28 | Journal article
Source: Self-asserted source
Elisa Espinet

Versatile workflow for cell type–resolved transcriptional and epigenetic profiles from cryopreserved human lung

JCI Insight
2021-03-22 | Journal article
Contributors: Maria Llamazares-Prada; Elisa Espinet; Vedrana Mijošek; Uwe Schwartz; Pavlo Lutsik; Raluca Tamas; Mandy Richter; Annika Behrendt; Stephanie T. Pohl; Naja P. Benz et al.
Source: check_circle
Crossref

Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.

Oncogene
2021-03-10 | Journal article
Source: Self-asserted source
Elisa Espinet

Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin

Cancer Discovery
2021-03-01 | Journal article
Contributors: Elisa Espinet; Zuguang Gu; Charles D. Imbusch; Nathalia A. Giese; Magdalena Büscher; Mariam Safavi; Silke Weisenburger; Corinna Klein; Vanessa Vogel; Mattia Falcone et al.
Source: check_circle
Crossref

Abstract IA05: Viral Mimicry in Pancreatic Cancer

Oral Presentations - Invited Abstracts
2020-12-01 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Versatile workflow for storage, characterization and cell-type resolved transcriptional and epigenetic profiles of human lung samples (LSC-2020)

Molecular pathology and funct. genomics
2020-09-07 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models.

Molecular therapy. Methods & clinical development
2020-04-25 | Journal article
Source: Self-asserted source
Elisa Espinet

Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts

[]
2020-04-06 | Preprint
Source: Self-asserted source
Elisa Espinet

Versatile workflow for cell type resolved transcriptional and epigenetic profiles from cryopreserved human lung

[]
2020-04-03 | Preprint
Source: Self-asserted source
Elisa Espinet

Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer

[]
2020-03-20 | Preprint
Source: Self-asserted source
Elisa Espinet

Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.

Proceedings of the National Academy of Sciences of the United States of America
2018-01-19 | Journal article
Source: Self-asserted source
Elisa Espinet

Cellular deconvolution and expression analysis of Stromal and Epithelial cells directly isolated from human Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatology
2017-07 | Conference abstract
Part of ISSN: 1424-3903
Source: Self-asserted source
Elisa Espinet

Endothelial Notch1 Activity Facilitates Metastasis.

Cancer cell
2017-03 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.

Pancreas
2017-03 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Abstract B77: CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

Heterogeneity of Pancreatic Cancer
2016-12-15 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Abstract LB-120: CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

Experimental and Molecular Therapeutics
2016-07-15 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Abstract IA22: CYP3A5 mediates resistance to small molecule inhibitors in a subtype of pancreatic ductal adenocarcinoma

Metastatic Cell Plasticity
2016-04-01 | Conference abstract
Source: Self-asserted source
Elisa Espinet

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Nature medicine
2016-03 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Abstract A61: Exploring the PDAC-subtype-associated microenvironment in PDX models and patients

Inflammation/Stroma
2015-07-01 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Abstract A69: A novel mechanism mediates drug resistance in the exocrine-like pancreatic ductal adenocarcinoma (PDAC) subtype

Heterogeneity in Tumor Progression
2015-07-01 | Conference abstract
Source: Self-asserted source
Elisa Espinet

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.

Nature genetics
2015-04 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Immunostaining Protocol: P-Smad2 (Xenograft and Mice)

BIO-PROTOCOL
2014 | Journal article
Part of ISSN: 2331-8325
Source: Self-asserted source
Elisa Espinet

Immunostaining Protocol: P-Stat3 (Xenograft and Mice)

BIO-PROTOCOL
2014 | Journal article
Part of ISSN: 2331-8325
Source: Self-asserted source
Elisa Espinet

Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.

Cancer cell
2012-11 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Functional isocyanide metal complexes as building blocks for supramolecular materials: hydrogen-bonded liquid crystals.

Dalton transactions (Cambridge, England : 2003)
2007-08 | Journal article
Source: Self-asserted source
Elisa Espinet via Europe PubMed Central

Peer review (6 reviews for 4 publications/grants)

Review activity for Cell death discovery. (2)
Review activity for EMBO journal. (1)
Review activity for Gut (2)
Review activity for npj precision oncology. (1)